U.S. markets open in 8 hours 11 minutes
  • S&P Futures

    4,125.75
    +7.75 (+0.19%)
     
  • Dow Futures

    33,699.00
    +75.00 (+0.22%)
     
  • Nasdaq Futures

    13,823.75
    +25.00 (+0.18%)
     
  • Russell 2000 Futures

    2,252.10
    +7.10 (+0.32%)
     
  • Crude Oil

    63.02
    -0.13 (-0.21%)
     
  • Gold

    1,740.60
    +4.30 (+0.25%)
     
  • Silver

    25.54
    +0.02 (+0.06%)
     
  • EUR/USD

    1.1982
    -0.0001 (-0.01%)
     
  • 10-Yr Bond

    1.6380
    0.0000 (0.00%)
     
  • Vix

    16.99
    +0.34 (+2.04%)
     
  • GBP/USD

    1.3766
    -0.0014 (-0.10%)
     
  • USD/JPY

    108.8610
    -0.0660 (-0.06%)
     
  • BTC-USD

    62,906.81
    -809.35 (-1.27%)
     
  • CMC Crypto 200

    1,370.23
    -5.54 (-0.40%)
     
  • FTSE 100

    6,939.58
    +49.09 (+0.71%)
     
  • Nikkei 225

    29,646.00
    +25.01 (+0.08%)
     

Earnings Preview: HTG Molecular Diagnostics

  • Oops!
    Something went wrong.
    Please try again later.
Benzinga Insights
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

On Tuesday, August 11, HTG Molecular Diagnostics (NASDAQ: HTGM) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.

Earnings and Revenue

Sell-side analysts are expecting HTG Molecular Diagnostics's earnings per share to be near $-0.08 on sales of $1.79 million. HTG Molecular Diagnostics EPS in the same period a year ago totaled $-0.17. Sales were $5.80 million. The Wall Street estimate would represent a 52.94% increase in the company's earnings. Here's how the company's reported EPS has stacked up against analyst estimates in the past:

EPS Estimate

-0.10

-0.09

-0.16

-0.15

EPS Actual

-0.08

-0.01

-0.15

-0.17

Revenue Estimate

3.04 M

4.85 M

5.47 M

5.56 M

Revenue Actual

2.23 M

4.80 M

5.41 M

5.80 M

Stock Performance

Over the past 52-week period, shares of HTG Molecular Diagnostics have declined 41.13%. Given that these returns are generally negative, long-term shareholders are probably a little upset going into this earnings release.

View more earnings on HTGM

Don't be surprised to see the stock move on comments made during its conference call. HTG Molecular Diagnostics is scheduled to hold the call at 16:30:00 ET and can be accessed here: http://public.viavid.com/player/index.php?id=140583

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.